Boxer Capital’s Million Corvus Bet Signals Confidence
Boxer Capital quietly boosted its stake in Corvus Pharmaceuticals, a move that signals institutional faith in the bio...
Choosing points over cash back can be beneficial in specific situations. Understand when to make that switch for better rewards.
27,195 articlesBoxer Capital quietly boosted its stake in Corvus Pharmaceuticals, a move that signals institutional faith in the bio...
A trusted market voice pivots from saying there’s no bubble to warning of growing chaos as IPO activity accelerates a...
SpaceX shares have tumbled from their peak, trading around $125 as of mid-July 2026. Analysts debate whether the retr...
Investors are parsing sector headlines as analysts cut targets for airlines and other cyclical stocks. This guide bre...
Citi lifts Coca-Cola's price target to $91 from $90, citing the World Cup marketing push as a key catalyst. The move ...
A $150,000 dividend income stream can look generous, but the IRS taxes it differently depending on how the income is ...
When a CEO unloads a big chunk of stock, investors take note. This article digs into sentinelone's sold over 39,000 s...
Starting with $1,000 doesn’t limit your ability to build lasting passive income. This guide presents two dependable d...
Suze Orman promotes a staged investing plan for people with large cash cushions, favoring dollar-cost averaging into ...
TransMedics has surged 104% over the last year, catching investors’ eyes. This guide breaks down the business, the ca...
Intuitive Surgical dominates robotic-assisted surgery, and its moat is getting stronger. This piece breaks down why t...
Are patient investors finally getting a chance to weigh SpaceX as a long-term growth play? This guide explains how a ...